论文部分内容阅读
新修订出台的《药品管理法》对医药企业提出了新的要求,为迅速适应市场形势的变化,全面提高全体员工的法律意识,严格依法生产经营,确保药品合格、安全,哈药集团有限公司于日前召开了“学习贯彻新《药品管理法》报告会”。国家药品监督管理局张文周副局长应邀为集团的高级职员作了专题报告。 张文周副局长着重对《药品管理法》中与企业生产经营密切相关的重要内容以及如何贯彻执行《药品管理法》等问题进行了深入细致的宣讲。张副局长还就企业如何贯彻执行药品质量认证制度、新药研制机构管理规范、药品分类管理制度、药品不良反应管理制度等药品管理相关制度作出了明确指导。张副局长指出,医
The newly revised “Drug Administration Law” puts forward new requirements for pharmaceutical companies. In order to quickly adapt to changes in the market situation, comprehensively improve the legal awareness of all employees, strictly in accordance with the law of production and management, ensure that medicines are qualified and safe. Harbin Pharmaceutical Group Co., Ltd. The “Report on Learning and Implementing the New Drug Administration Law” was held a few days ago. The Deputy Director of the State Drug Administration Zhang Wenzhou was invited to give a special report to the senior staff of the Group. Deputy Director Zhang Wenzhou focused on the important contents of the Pharmaceutical Administration Law that are closely related to the production and operation of the company and how to implement the Drug Administration Law. Deputy Director Zhang also gave clear guidance on how pharmaceutical companies implement the drug quality certification system, management guidelines for new drug development institutions, drug classification management system, and drug adverse reaction management system. Deputy Director Zhang pointed out that the doctor